लोड हो रहा है...

Lessons From the Development of the Immune Checkpoint Inhibitors in Oncology

Immunotherapies are becoming increasingly important in the treatment armamentarium of a variety of malignancies. Immune checkpoint inhibitors are the most representative drugs receiving regulatory approval over the past few years. In a recent study published in Clinical Cancer Research, we demonstra...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Integr Cancer Ther
मुख्य लेखकों: Jardim, Denis L., de Melo Gagliato, Débora, Kurzrock, Razelle
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: SAGE Publications 2018
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6247554/
https://ncbi.nlm.nih.gov/pubmed/30229677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1534735418801524
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!